Literature DB >> 11122035

A case of erythrokeratoderma variabilis without mutations in connexin 31.

A Ishida-Yamamoto1, D Kelsell, J Common, M J Houseman, M Hashimoto, H Shibaki, K Asano, H Takahashi, Y Hashimoto, T Senshu, I M Leigh, H Iizuka.   

Abstract

Erythrokeratoderma (EK) variabilis is a heterogeneous group of diseases characterized by migratory erythematous patches and hyperkeratotic plaques. Mutations in connexin 31 have recently been found to underlie several cases of EK variabilis. We describe a Japanese girl with extensive lesions that appeared to be a form of EK variabilis, clinically resembling genodermatose en cocardes (Degos). Our patient had characteristic migratory rosette or target-like erythematous keratotic plaques with peripheral scaling in addition to relatively fixed keratotic plaques. Sequencing of the connexin 31 gene did not detect mutations. Skin biopsy showed parakeratotic hyperkeratosis with hypergranulosis. Immunohistochemically, suprabasal keratins, involucrin and profilaggrin were unequivocally expressed, while loricrin expression was greatly diminished and deiminated K1 was undetectable. Our results confirm aetiological heterogeneity in EK. The histological features suggest disruption of keratinocyte terminal differentiation at a very late stage.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11122035     DOI: 10.1046/j.1365-2133.2000.03902.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  2 in total

1.  Erythrokeratodermia variabilis: Two case reports.

Authors:  Ayse Serap Karadag; Serap Gunes Bilgili; Omer Calka; Irfan Bayram
Journal:  Indian Dermatol Online J       Date:  2013-10

2.  The desmosome is a mesoscale lipid raft-like membrane domain.

Authors:  Joshua D Lewis; Amber L Caldara; Stephanie E Zimmer; Sara N Stahley; Anna Seybold; Nicole L Strong; Achilleas S Frangakis; Ilya Levental; James K Wahl; Alexa L Mattheyses; Takashi Sasaki; Kazuhiko Nakabayashi; Kenichiro Hata; Yoichi Matsubara; Akemi Ishida-Yamamoto; Masayuki Amagai; Akiharu Kubo; Andrew P Kowalczyk
Journal:  Mol Biol Cell       Date:  2019-04-03       Impact factor: 4.138

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.